I-MAK’s Tahir Amin on Washington Business Tonight Discussing the Case Against Abbott’s Drug Kaletra

Video/Audio 4 Mar 2010

I-MAK Director, Tahir Amin, interviewed by Washington Business Tonight about Abbott Laboratories patents on the drug Kaletra.

Next Post:

Racial disparities create obstacles for Covid-19 vaccine rollout

 Back to the Latest Page

Partner with us now to build
a more just and equitable
medicine system for all.